trending Market Intelligence /marketintelligence/en/news-insights/trending/UXJgAZBkA2f05TOVNfLmSA2 content esgSubNav
In This List

Acasti Pharma falls out of compliance with Nasdaq listing requirement

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Acasti Pharma falls out of compliance with Nasdaq listing requirement

Canada's Acasti Pharma Inc. said it was no longer in compliance with Nasdaq's $1 minimum bid price listing requirement.

The drugmaker has until June 24, with a possibly of extension, to regain compliance.

The development has no immediate effect on Acasti's listing. The company said it will evaluate all available options to resolve the deficiency.